TGFB2 and systemic sclerosis: Constitutive activation of TGFβ2 (but not TGFβ1 or TGFβ3) caused by epigenetic modulation of a discrete TGFβ2 enhancer, which is enforced by BRD4 and NF-κB, drives profibrotic programs in SSc fibroblasts (112).